RATIONALE: Fear conditioning reliably increases the startle reflex and stress hormones, yet very little is known about the effect of stress hormones on fear-potentiated startle. Cortisol and the sulfate ester of dehydroepiandrosterone (DHEA-S) are involved in stress and anxiety. Evidence suggests that low cortisol/DHEA-S ratio has a buffering effect on stress and anxiety in preclinical and clinical studies, suggesting that there may be a relationship between fear-potentiated startle and cortisol and DHEA-S activity. OBJECTIVE: The aim of the study was to examine whether there is a relationship between cortisol/DHEA-S ratio and fear-potentiated startle. METHODS: Thirty healthy subjects participated in a differential aversive conditioning experiment during which one of two stimuli (CS+) was paired with a shock, and the other was not (CS-). Conditioned responses were assessed with the startle reflex, defined as startle potentiation during CS+ compared to CS-. DHEA-S and cortisol levels were assayed from blood samples collected in both a baseline and an aversive conditioning session. Subjective state anxiety, arousal, and valence were assessed at various times during testing. RESULTS: Fear-potentiated startle was larger in individuals with high compared to low cortisol/DHEA-S ratio. Multiple regression analyses revealed that fear-potentiated startle was positively associated with cortisol and negatively associated with DHEA-S. There was no significant correlation between DHEA-S and cortisol levels. CONCLUSION: These data suggest that cortisol and DHEA-S are involved in fear conditioning.
RATIONALE: Fear conditioning reliably increases the startle reflex and stress hormones, yet very little is known about the effect of stress hormones on fear-potentiated startle. Cortisol and the sulfate ester of dehydroepiandrosterone (DHEA-S) are involved in stress and anxiety. Evidence suggests that low cortisol/DHEA-S ratio has a buffering effect on stress and anxiety in preclinical and clinical studies, suggesting that there may be a relationship between fear-potentiated startle and cortisol and DHEA-S activity. OBJECTIVE: The aim of the study was to examine whether there is a relationship between cortisol/DHEA-S ratio and fear-potentiated startle. METHODS: Thirty healthy subjects participated in a differential aversive conditioning experiment during which one of two stimuli (CS+) was paired with a shock, and the other was not (CS-). Conditioned responses were assessed with the startle reflex, defined as startle potentiation during CS+ compared to CS-. DHEA-S and cortisol levels were assayed from blood samples collected in both a baseline and an aversive conditioning session. Subjective state anxiety, arousal, and valence were assessed at various times during testing. RESULTS: Fear-potentiated startle was larger in individuals with high compared to low cortisol/DHEA-S ratio. Multiple regression analyses revealed that fear-potentiated startle was positively associated with cortisol and negatively associated with DHEA-S. There was no significant correlation between DHEA-S and cortisol levels. CONCLUSION: These data suggest that cortisol and DHEA-S are involved in fear conditioning.
Authors: Brigitte M Kudielka; Nicole C Schommer; Dirk H Hellhammer; Clemens Kirschbaum Journal: Psychoneuroendocrinology Date: 2004-09 Impact factor: 4.905
Authors: Mar M Sánchez; Pamela M Noble; Casie K Lyon; Paul M Plotsky; Michael Davis; Charles B Nemeroff; James T Winslow Journal: Biol Psychiatry Date: 2005-02-15 Impact factor: 13.382
Authors: Tanja Jovanovic; Sandor Szilagyi; Subhajit Chakravorty; Ana M Fiallos; Barbara J Lewison; Arti Parwani; Marion P Schwartz; Stephen Gonzenbach; John P Rotrosen; Erica J Duncan Journal: Psychophysiology Date: 2004-05 Impact factor: 4.016
Authors: Ann M Rasmusson; Jitka Vasek; Deborah S Lipschitz; Dolores Vojvoda; Mary Ellen Mustone; Quihu Shi; Gretchen Gudmundsen; Charles A Morgan; Jessica Wolfe; Dennis S Charney Journal: Neuropsychopharmacology Date: 2004-08 Impact factor: 7.853
Authors: Christian Grillon; Randi Heller; Elizabeth Hirschhorn; Mitchel A Kling; Daniel S Pine; Jay Schulkin; Meena Vythilingam Journal: Biol Psychiatry Date: 2011-01-31 Impact factor: 13.382
Authors: Vasiliki Michopoulos; Alex O Rothbaum; Elizabeth Corwin; Bekh Bradley; Kerry J Ressler; Tanja Jovanovic Journal: Arch Womens Ment Health Date: 2014-10-03 Impact factor: 3.633
Authors: Mark W Miller; Ann E McKinney; Fredrick S Kanter; Kristina J Korte; William R Lovallo Journal: Psychoneuroendocrinology Date: 2011-01-26 Impact factor: 4.905
Authors: Jennifer L McGuire; Hadley C Bergstrom; Clarissa C Parker; Thien Le; Maria Morgan; Haiying Tang; Reed G Selwyn; Afonso C Silva; Kwang Choi; Robert J Ursano; Abraham A Palmer; Luke R Johnson Journal: Eur J Neurosci Date: 2013-08-22 Impact factor: 3.386
Authors: Rachel Grashow; Mark W Miller; Ann McKinney; Linda H Nie; David Sparrow; Howard Hu; Marc G Weisskopf Journal: Neurotoxicol Teratol Date: 2013-04-17 Impact factor: 3.763